Translating Mismatch Repair Mechanism into Cancer Care
Journal:
Current Drug Targets
Volume:
15
Page:
53-64
Author(s):
Christopher D. Heinen
Targeting the BRCA1/2 Tumor Suppressors
Journal:
Current Drug Targets
Volume:
15
Page:
17-31
Author(s):
Eliot M. Rosen and Michael J. Pishvaian
Editorial (Thematic Issue: Systems and Network Biology in Pharmaceutical Drug Discovery)
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2-3
Author(s):
Asfar S. Azmi
Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
88-100
Author(s):
Sophie Domhan, Christian Schwager, Quanxiang Wei, Stefan Muschal, Claudia Sommerer, Christian Morath, Wolfgang Wick, Christian Maercker, Jurgen Debus, Martin Zeier, Peter E. Huber and Amir Abdollahi
1,2,3-Triazine Scaffold as a Potent Biologically Active Moiety: A Mini Review
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
72-83
Author(s):
Rajeev Kumar, Amar Deep Singh, Jitendra Singh, Hariram Singh, R.K. Roy and Anurag Chaudhary
Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
66-72
Author(s):
Andreas Mock, Sara Chiblak and Christel Herold-Mende
Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
2-29
Author(s):
Joao Figueiredo, Odete A. B. da Cruz e Silva and Margarida Fardilha
New Approaches to Target Cancer Stem Cells: Current Scenario
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
20-34
Author(s):
Mayank Bashyal Insan and Vikas Jaitak
Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
79-90
Author(s):
Arun Kanakkanthara, Jonathan Eras, Peter T. Northcote, Fernando Cabral and John H. Miller
Cyclophilin A as a Target of Cisplatin Chemosensitizers
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
46-58
Author(s):
Gerhard Hamilton